P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

por Kowanetz, M, Vu, MT, Wu, J, Koeppen, H, Kohrt, H, Gettinger, S, Cruz, C, Denker, M, Chen, DS, Hegde, P
Publicado 2014

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

por Gray, H. J., Benigno, B., Berek, J., Chang, J., Mason, J., Mileshkin, L., Mitchell, P., Moradi, M., Recio, F. O., Michener, C. M., Secord, A. Alvarez, Tchabo, N E., Chan, J. K., Young, J., Kohrt, H., Gargosky, S. E., Goh, J. C.
Publicado 2016

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats

por Walters, M J, Ebsworth, K, Berahovich, R D, Penfold, M E T, Liu, S-C, Al Omran, R, Kioi, M, Chernikova, S B, Tseng, D, Mulkearns-Hubert, E E, Sinyuk, M, Ransohoff, R M, Lathia, J D, Karamchandani, J, Kohrt, H E K, Zhang, P, Powers, J P, Jaen, J C, Schall, T J, Merchant, M, Recht, L, Brown, J M
Publicado 2014

Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens

por Khodadoust, M.S., Olsson, N., Wagar, L.E., Haabeth, O.A.W., Chen, B., Swaminathan, K., Rawson, K., Liu, C.L., Steiner, D., Lund, P., Rao, S., Zhang, L., Marceau, C., Stehr, H., Newman, A.M., Czerwinski, D. K., Carlton, V.E.H., Moorhead, M., Faham, M., Kohrt, H.E., Carette, J., Green, M.R., Davis, M.M., Levy, R., Elias, J. E., Alizadeh, A.A.
Publicado 2017